Value of Supportive Care Pharmacogenomics in Oncology Practice.
Jai Narendra PatelLauren A WiebeHenry M DunnenbergerHoward L McLeodPublished in: The oncologist (2018)
Integration of palliative medicine into the cancer care continuum has resulted in increased quality of life and survival for patients with many cancer types. However, suboptimal management of symptoms such as pain, neuropathy, depression, and nausea and vomiting continues to place a heavy burden on patients with cancer. As demonstrated in this theoretical case, pharmacogenomics can have a major effect on clinical response to medications used to treat these conditions. Recognizing the value of supportive care pharmacogenomics in oncology and application into routine practice offers an objective choice for the safest and most effective treatment compared with the traditional trial and error method.
Keyphrases
- palliative care
- healthcare
- quality improvement
- advanced cancer
- primary care
- pain management
- adverse drug
- clinical decision support
- papillary thyroid
- chronic pain
- sleep quality
- depressive symptoms
- clinical trial
- study protocol
- squamous cell
- affordable care act
- phase ii
- clinical practice
- health insurance
- combination therapy
- young adults
- open label
- lymph node metastasis